Sacral nerve neurostimulation-neuromodulation in the treatment of lower urinary tract dysfunction. Basic principles-indications-clinical application-results

被引:0
|
作者
Spyropoulos, E. [1 ]
机构
[1] Navy Hosp Athens, Urol Clin, Athens, Greece
来源
ARCHIVES OF HELLENIC MEDICINE | 2007年 / 24卷 / 02期
关键词
Idiopathic urinary retention; Neuromodulation; Neurostimulation; Overactive bladder; Sacral nerves; Urge urinary incontinence;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
During the last fifteen years, sacral nerve neuromodulation-neurostimulation has begun to be developed as a therapeutic tool for the treatment of refractory chronic lower urinary tract dysfunction. This is a comprehensive review of the current state of the art of this surgical innovation in terms of basic principles, indications, clinical application, complications and results. The mode of action of neuromodulation is still not fully understood, but it is hypothesized that the electrical current modulates reflex pathways involved in the filling and evacuation phases of the micturition cycle, rebalancing micturition control. The main indication for intervention is chronic voiding dysfunction, refractory to conventional treatments, causing urgency-frequency syndrome, urge incontinence and idiopathic (non-neurogenic) voiding difficulty. Less common indications are multiple sclerosis, suprasacral spinal cord injuries, stroke, and Parkinson's disease. Its clinical application consists principally of three stages: Percutaneous location of the sacral spinal nerve with a needle electrode, percutaneous test stimulation with wire electrodes to assess the therapeutic potential in the individual patient over a period of 4 to 14 days, and permanent implantation of the neurostimulation device. Complications are usually minimal (rate 22-43%) and can be classified into surgery-related morbidity, neurophysiological alterations and hardware problems. The mean total clinical success rate has been estimated to be 88%, 80% and 71% in cases of urgency-frequency, urge incontinence and idiopathic urinary retention, respectively. On the basis of these results, it appears that sacral nerve neuromodulation represents an effective alternative treatment modality in patients with various forms of chronic lower urinary tract dysfunction refractory to conventional treatment, successfully bridging the gap between conservative treatment options and highly invasive surgical procedures.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 6 条
  • [1] Peripheral and Sacral Neuromodulation in the Treatment of Neurogenic Lower Urinary Tract Dysfunction
    Romo, Paholo G. Barboglio
    Gupta, Priyanka
    UROLOGIC CLINICS OF NORTH AMERICA, 2017, 44 (03) : 453 - +
  • [2] Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction
    Grünewald, V
    Höfner, K
    Thon, WF
    Kuczyk, MA
    Jonas, U
    RESTORATIVE NEUROLOGY AND NEUROSCIENCE, 1999, 14 (2-3) : 189 - 193
  • [3] Sacral neuromodulation for treatment of dysfunctions ofthe lower urinary tract.: An overview of 'the principle, indications and results
    Bannowsky, A
    Seif, C
    Sugimoto, S
    Böhler, G
    van der Horst, C
    Bross, S
    Alken, P
    Jünemann, KP
    Braun, PM
    UROLOGE A, 2003, 42 (10): : 1357 - 1365
  • [4] Initial experience with sacral neuromodulation for the treatment of lower urinary tract dysfunction in Brazil
    Seabra Rios, Luis Augusto
    Averbeck, Marcio Augusto
    Franca, Wagner
    Ricetto Sacomani, Carlos Alberto
    Almeida, Fernando G.
    Gomes, Cristiano Mendes
    INTERNATIONAL BRAZ J UROL, 2016, 42 (02): : 312 - 320
  • [5] Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: A retrospective single center study
    van Voskuilen, AC
    Oerlemans, DJAJ
    Weil, EHJ
    de Bie, RA
    van Kerrebroeck, PEVA
    EUROPEAN UROLOGY, 2006, 49 (02) : 366 - 372
  • [6] Sacral Neuromodulation with the InterStim™ System for Intractable Lower Urinary Tract Dysfunctions (SOUNDS): Results of Clinical Effectiveness, Quality of Life, Patient-Reported Outcomes and Safety in a French Multicenter Observational Study
    Chartier-Kastler, Emmanuel
    Le Normand, Loic
    Ruffion, Alain
    Dargent, Francois
    Braguet, Raissa
    Saussine, Christian
    Tanneau, Yves
    Graziana, Jean Pierre
    Ragni, Evelyne
    Rabut, Bertrand
    Rousseau, Thierry
    Biardeau, Xavier
    Game, Xavier
    Pierrevelcin, Jean
    Brassart, Elena
    Fourmarier, Marc
    Stoica, Gabriel
    Berrogain, Nathalie
    Yaghi, Najdat
    Pecoux, Francois
    Capon, Gregoire
    Ferchaud, Jerome
    Peyrat, Laurence
    Bryckaert, Pierre Emmanuel
    Karsenty, Gilles
    Melotti, Alice
    Abouihia, Abdallah
    Keller, David Urs Josef
    Cornu, Jean-Nicolas
    EUROPEAN UROLOGY FOCUS, 2021, 7 (06): : 1430 - 1437